{"filings":[{"id":528156,"accession_number":"0000046250-26-000020","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2026-05-19T20:42:30+00:00","items":["5.02"],"status":"ready","headline":"Shirley Rozeboom no longer executive officer at Hawkins; remains VP – Stauber","event_type":"leadership","confidence":"high","bullets":["Shirley A. Rozeboom, Vice President – Stauber, removed from executive officer designation effective May 13, 2026.","Change part of planned transition due to reporting segment realignment first effective FY ended March 29, 2026.","Ms. Rozeboom continues as an employee of Hawkins, Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":68322,"accession_number":"0000046250-26-000017","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2026-05-13T20:13:03+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hawkins Q4 sales record $265.9M, FY sales $1.1B; FY diluted EPS $3.91 down 3%","event_type":"earnings","confidence":"high","bullets":["Record Q4 sales $265.9M (+8% YoY); FY sales $1.1B (+11%) driven by Water Treatment +22%.","FY diluted EPS $3.91 (-3% YoY); adjusted EBITDA $179.0M (+6%); operating cash flow $144.3M (+30%).","Water Treatment segment sales $543.3M (+22%), now 50% of total revenue; 6 acquisitions completed in FY2026.","Amortization, interest, and earnout accretion from acquisitions reduced EPS; pro forma EPS +9% if WaterSurplus included.","Expects leverage ratio ~1x adj. EBITDA by end FY2027; dividend $0.75/share (+7%), 41st consecutive year."],"consensus_eps_estimate":null,"consensus_eps_actual":3.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":1083696000.0,"consensus_period":"2026-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113458,"accession_number":"0000046250-26-000004","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2026-01-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hawkins Q3 FY2026 revenue $244.1M (+8% YoY); EPS $0.69 (-4%) on acquisition costs","event_type":"earnings","confidence":"high","bullets":["Net income $14.3M vs $15.0M YoY; diluted EPS $0.69 vs $0.72; pro forma EPS up ~10% if WaterSurplus had closed earlier.","Revenue growth driven by Water Treatment (+21%) and Industrial Solutions (+10%); Food & Health Sciences fell 10%.","Adjusted EBITDA $34.8M (+3%); operating cash flow $35M used to repay $15M debt; leverage ratio 1.47x.","Six acquisitions completed in FY2026; $4-5M quarterly expense from amortization, earn-out, interest; expected accretive in FY2027.","Management sees food end-market pricing pressure; targets return to historical organic growth in FY2027."],"consensus_eps_estimate":null,"consensus_eps_actual":3.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":817786000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129843,"accession_number":"0000046250-25-000059","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hawkins VP, General Counsel & Secretary Richard Erstad to retire effective Dec 28, 2025","event_type":"leadership","confidence":"high","bullets":["Richard G. Erstad plans to retire after 17 years as VP, General Counsel and Secretary.","He will cease serving as an executive officer on December 28, 2025 (end of Q3 fiscal).","Erstad will remain as an employee through May 2026 to ensure transition.","No successor has been named; the company describes a planned transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129842,"accession_number":"0000046250-25-000056","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hawkins reports record Q2 revenue of $280M, EPS down 7% on acquisition costs","event_type":"earnings","confidence":"high","bullets":["Revenue $280.4M (+14% YoY); Water Treatment +21%, Industrial +11%, Food & Health Sciences +2%.","Diluted EPS $1.08 vs $1.16 (-7%); adjusted EBITDA $50.4M (+9%); trailing 12-month adj. EBITDA >$178M.","WaterSurplus acquisition expected to incur $17M expenses in FY2026; accretive in FY2027.","Repaid $20M on line of credit during quarter; leverage ratio 1.53x vs 0.86x at FY2025 end.","Reporting segments realigned: Food and Health Sciences now includes formerly Industrial businesses."],"consensus_eps_estimate":null,"consensus_eps_actual":2.48,"consensus_revenue_estimate":null,"consensus_revenue_actual":573706000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146431,"accession_number":"0000046250-25-000048","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Hawkins realigns reporting segments to Water Treatment, Food & Health Sciences, Industrial Solutions","event_type":"other_material","confidence":"high","bullets":["New segments: Water Treatment (unchanged), Food & Health Sciences (includes nutrition, food, ag, pharma), Industrial Solutions.","Historical financial data for fiscal years 2021–2025 and quarterly periods recast under new structure provided.","Realignment effective Q1 FY2026; reflects shift from bulk commodity distributor to specialty ingredients company.","Food, Agriculture, and Pharmaceutical businesses moved from former Industrial segment into Food & Health Sciences.","No change in how Water Treatment segment is managed; all prior period figures restated for comparability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146430,"accession_number":"0000046250-25-000045","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Hawkins shareholders elect directors, ratify auditor, approve say-on-pay at annual meeting","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; highest vote total for Yi \"Faith\" Tang with 14,724,250 for.","Deloitte & Touche LLP ratified as independent auditor for FY2026 with 16,912,506 votes for.","Advisory say-on-pay approved with 14,131,359 votes for, 594,854 against.","Broker non-votes of 2,190,871 on director elections and say-on-pay proposal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146429,"accession_number":"0000046250-25-000041","cik":46250,"company_name":"HAWKINS INC","ticker":"HWKN","form_type":"8-K","filed_at":"2025-07-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Hawkins Q1 FY2026: record revenue $293M, EPS $1.40, Water Treatment sales +28%","event_type":"earnings","confidence":"high","bullets":["Revenue $293.3M (+15% YoY); diluted EPS $1.40 vs $1.38; adjusted EBITDA $57.6M (+13%).","Water Treatment segment revenue $149.6M (+28%), driven by acquisitions and volume growth.","Closed WaterSurplus acquisition in quarter; $29M added sales from acquired businesses.","Net debt $299M; leverage ratio 1.61x trailing adjusted EBITDA vs 0.86x at FY2025 end.","Management expects all three segments to grow profitability in fiscal 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":1.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":293272000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}